Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26290450)

  • 1. PHD1 regulates p53-mediated colorectal cancer chemoresistance.
    Deschoemaeker S; Di Conza G; Lilla S; Martín-Pérez R; Mennerich D; Boon L; Hendrikx S; Maddocks OD; Marx C; Radhakrishnan P; Prenen H; Schneider M; Myllyharju J; Kietzmann T; Vousden KH; Zanivan S; Mazzone M
    EMBO Mol Med; 2015 Oct; 7(10):1350-65. PubMed ID: 26290450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.
    Rawluszko AA; Bujnicka KE; Horbacka K; Krokowicz P; Jagodziński PP
    BMC Cancer; 2013 Nov; 13():526. PubMed ID: 24195777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53-MDM2 interaction in a hydroxylase-independent manner.
    Xu Y; Gao Q; Xue Y; Li X; Xu L; Li C; Qin Y; Fang J
    J Biol Chem; 2019 Jun; 294(25):9949-9958. PubMed ID: 31092600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHD1 interacts with ATF4 and negatively regulates its transcriptional activity without prolyl hydroxylation.
    Hiwatashi Y; Kanno K; Takasaki C; Goryo K; Sato T; Torii S; Sogawa K; Yasumoto K
    Exp Cell Res; 2011 Dec; 317(20):2789-99. PubMed ID: 21951999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
    Fox SB; Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Bersiga A; Allevi G; Milani M; Aguggini S; Mele T; Dogliotti L; Bottini A; Harris AL
    Breast Cancer Res; 2011 Feb; 13(1):R16. PubMed ID: 21291529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
    Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
    Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel induced-JNK2/PHD1 signaling pathway increases degradation of HIF-1α and causes cancer cell death under hypoxia.
    Oh ET; Kim CW; Kim SJ; Lee JS; Hong SS; Park HJ
    Sci Rep; 2016 Jun; 6():27382. PubMed ID: 27263528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
    Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATF4-mediated microRNA-145/HDAC4/p53 axis affects resistance of colorectal cancer cells to 5-fluorouracil by regulating autophagy.
    Zhao L; Chen H; Zhang Q; Ma J; Hu H; Xu L
    Cancer Chemother Pharmacol; 2022 May; 89(5):595-607. PubMed ID: 35312836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proline Hydroxylation Primes Protein Kinases for Autophosphorylation and Activation.
    Lee SB; Ko A; Oh YT; Shi P; D'Angelo F; Frangaj B; Koller A; Chen EI; Cardozo T; Iavarone A; Lasorella A
    Mol Cell; 2020 Aug; 79(3):376-389.e8. PubMed ID: 32640193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The loss of SHMT2 mediates 5-fluorouracil chemoresistance in colorectal cancer by upregulating autophagy.
    Chen J; Na R; Xiao C; Wang X; Wang Y; Yan D; Song G; Liu X; Chen J; Lu H; Chen C; Tang H; Zhuang G; Fan G; Peng Z
    Oncogene; 2021 Jun; 40(23):3974-3988. PubMed ID: 33990700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity.
    Xue J; Li X; Jiao S; Wei Y; Wu G; Fang J
    Gastroenterology; 2010 Feb; 138(2):606-15. PubMed ID: 19786027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation.
    Neitzel C; Seiwert N; Göder A; Diehl E; Weber C; Nagel G; Stroh S; Rasenberger B; Christmann M; Fahrer J
    Cells; 2019 Jul; 8(8):. PubMed ID: 31366086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway.
    Liang Y; Hou L; Li L; Li L; Zhu L; Wang Y; Huang X; Hou Y; Zhu D; Zou H; Gu Y; Weng X; Wang Y; Li Y; Wu T; Yao M; Gross I; Gaiddon C; Luo M; Wang J; Meng X
    Oncogene; 2020 Jan; 39(2):469-485. PubMed ID: 31597953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenacissoside G synergistically potentiates inhibitory effects of 5-fluorouracil to human colorectal cancer.
    Wang K; Liu W; Xu Q; Gu C; Hu D
    Phytomedicine; 2021 Jun; 86():153553. PubMed ID: 33906076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation-induced silencing of ASC and the effect of expressed ASC on p53-mediated chemosensitivity in colorectal cancer.
    Ohtsuka T; Liu XF; Koga Y; Kitajima Y; Nakafusa Y; Ha CW; Lee SW; Miyazaki K
    Oncogene; 2006 Mar; 25(12):1807-11. PubMed ID: 16331272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin.
    Faruk M; Ibrahim S; Aminu SM; Adamu A; Abdullahi A; Suleiman AM; Rafindadi AH; Mohammed A; Iliyasu Y; Idoko J; Saidu R; Randawa AJ; Musa HS; Ntekim A; Shah KZ; Abubakar S; Adoke KU; Manko M; Awasum CA
    PLoS One; 2021; 16(1):e0245581. PubMed ID: 33465114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Hippel-Lindau-dependent patterns of RNA polymerase II hydroxylation in human renal clear cell carcinomas.
    Yi Y; Mikhaylova O; Mamedova A; Bastola P; Biesiada J; Alshaikh E; Levin L; Sheridan RM; Meller J; Czyzyk-Krzeska MF
    Clin Cancer Res; 2010 Nov; 16(21):5142-52. PubMed ID: 20978146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic antiprotozoal thiazolide drug induced apoptosis in colorectal cancer cells: implications of IL-6/JAK2/STAT3 and p53/caspases-dependent signaling pathways based on molecular docking and in vitro study.
    Tantawy MA; El-Sherbeeny NA; Helmi N; Alazragi R; Salem N; Elaidy SM
    Mol Cell Biochem; 2020 Jun; 469(1-2):143-157. PubMed ID: 32356241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
    Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
    Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.